Physician

Jason Michael Weaver, M.D.

According to 2025 Medicare claims, Jason Weaver, M.D. (NPI: 1801996517) practices dermatology in the College Station-Bryan, TX market, with the plurality of this provider's patient population coming from Brazos, TX. This provider's primary affiliated billing organization is JASON M. WEAVER, MD, PA (NPI: 1043363666; TIN: 205959298) and primary practice location at 77802-5948.

Weaver's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,807 traditional Medicare patients, billed 12,886 HCPCS/CPT codes, and received $514,971 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,477 prescription claims across 730 beneficiaries totaling $140,913 in drug costs, led by Otezla (Apremilast). Open Payments data shows 1 records totaling $16. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $129,530 and ending at $140,913. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$337K$674K2015 Medicare payment: $588,662 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $521,898 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $568,289 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $490,902 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $565,201 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $532,123 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $668,400 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $674,445 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $571,632 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $514,971 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,95215,853$588,662
20161,82814,015$521,898
20172,01415,296$568,289
20181,95716,379$490,902
20192,12416,793$565,201
20201,95917,947$532,123
20212,20119,272$668,400
20222,30218,398$674,445
20232,28715,709$571,632
20241,80712,886$514,971

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$70K$141K2015 Drug cost: $129,530 (USD; Tot_Drug_Cst)2016 Drug cost: $85,480 (USD; Tot_Drug_Cst)2017 Drug cost: $98,893 (USD; Tot_Drug_Cst)2018 Drug cost: $98,468 (USD; Tot_Drug_Cst)2019 Drug cost: $124,852 (USD; Tot_Drug_Cst)2020 Drug cost: $99,666 (USD; Tot_Drug_Cst)2021 Drug cost: $98,507 (USD; Tot_Drug_Cst)2022 Drug cost: $107,327 (USD; Tot_Drug_Cst)2023 Drug cost: $132,358 (USD; Tot_Drug_Cst)2024 Drug cost: $140,913 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015371785$129,530
2016362694$85,480
2017372753$98,893
2018435863$98,468
20195821,172$124,852
20205821,256$99,666
20216721,353$98,507
20226591,429$107,327
20237041,359$132,358
20247301,477$140,913

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths582711$74
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,5602,487$62
11102Biopsy of related skin growth, first growth314339$61
17000Destruction of precancer skin growth, 1 growth1,1371,657$37
17003Destruction of precancer skin growth, 2-14 growths8825,430$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast13390$62,786
JubliaEfinaconazole19607$22,215
FluorouracilFluorouracil993,014$6,809
Betamethasone DipropionateBetamethasone Dipropionate962,856$4,378
Clobetasol PropionateClobetasol Propionate1183,769$4,109

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$16Journey Medical Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jason Michael Weaver, M.D.?

Tedicare shows public-source Medicare data for Jason Michael Weaver, M.D. (NPI 1801996517), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason Michael Weaver, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jason Michael Weaver, M.D.?

Jason Michael Weaver, M.D. is linked to JASON M. WEAVER, MD, PA (billing NPI 1043363666) in the available physician profile data.

Does Jason Michael Weaver, M.D. have Open Payments data?

Jason Michael Weaver, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.